Jenny Devenport

Suggest Changes
Learn More
OBJECTIVE To assess the safety and tolerability of tocilizumab (TCZ) as monotherapy or in combination with nonbiologic disease-modifying antirheumatic drugs (DMARDs) in patients with moderate to(More)
OBJECTIVE To investigate the effect of tocilizumab on patient-reported outcomes (PROs) in RA patients with inadequate responses to TNF inhibitors (TNFis). METHODS In a Phase III randomized(More)